Found: 27
Select item for more details and to access through your institution.
Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.974423
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet Formulation.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1476, doi. 10.3390/pharmaceutics15051476
- By:
- Publication type:
- Article
Opportunities and Challenges for PBPK Model of mAbs in Paediatrics and Pregnancy.
- Published in:
- AAPS Journal, 2022, v. 24, n. 4, p. 1, doi. 10.1208/s12248-022-00722-0
- By:
- Publication type:
- Article
Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches.
- Published in:
- AAPS Journal, 2013, v. 15, n. 2, p. 377, doi. 10.1208/s12248-012-9446-2
- By:
- Publication type:
- Article
Use of modelling and simulation techniques to support decision making on the progression of PF-04878691, a TLR7 agonist being developed for hepatitis C.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 1, p. 77, doi. 10.1111/j.1365-2125.2011.04047.x
- By:
- Publication type:
- Article
Using facial muscular movements to understand young children's emotion regulation and concurrent neural activation.
- Published in:
- Developmental Science, 2018, v. 21, n. 5, p. 1, doi. 10.1111/desc.12628
- By:
- Publication type:
- Article
Creation of Novel Sensitive Probe Substrate and Moderate Inhibitor Models for a Comprehensive Prediction of CYP2C8 Interactions for Tucatinib.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 299, doi. 10.1002/cpt.3104
- By:
- Publication type:
- Article
Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 5, p. 976, doi. 10.1002/cpt.1955
- By:
- Publication type:
- Article
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 31, doi. 10.1007/s00228-007-0396-z
- By:
- Publication type:
- Article
Physiologically‐based pharmacokinetic modeling of the drug–drug interaction between ivacaftor and lefamulin in cystic fibrosis patients.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 589, doi. 10.1002/psp4.13103
- By:
- Publication type:
- Article
A comprehensive evaluation in clinic and physiologically‐based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450–mediated drug–drug interaction potential for pomotrelvir.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 10, p. 1553, doi. 10.1002/psp4.13034
- By:
- Publication type:
- Article
Development and application of a PBPK modeling strategy to support antimalarial drug development.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 9, p. 1335, doi. 10.1002/psp4.13013
- By:
- Publication type:
- Article
Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 4, p. 532, doi. 10.1002/psp4.12939
- By:
- Publication type:
- Article
PBPK perspective on alternative CYP3A4 inducers for rifampin.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 12, p. 1543, doi. 10.1002/psp4.12864
- By:
- Publication type:
- Article
A Physiologically‐Based Pharmacokinetic Model for the Prediction of "Half‐Life Extension" and "Catch and Release" Monoclonal Antibody Pharmacokinetics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 9, p. 534, doi. 10.1002/psp4.12547
- By:
- Publication type:
- Article
A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 10, p. 738, doi. 10.1002/psp4.12461
- By:
- Publication type:
- Article
Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A novel strategy for physiologically based predictions of human pharmacokinetics.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Cure4Kids: Two decades of knowledge transfer.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 12, p. 1, doi. 10.1002/pbc.30007
- By:
- Publication type:
- Article
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0226-x
- By:
- Publication type:
- Article
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-014-0097-x
- By:
- Publication type:
- Article
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-014-0097-x
- By:
- Publication type:
- Article
Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 6, p. 1417, doi. 10.1111/cts.13253
- By:
- Publication type:
- Article
Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article